NCT00501995View on ClinicalTrials.gov

High Dose Cyclophosphamide for Treatment of Scleroderma

PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

July 31, 2008

Study Completion Date

May 31, 2010

Conditions
Scleroderma
Interventions
DRUG

IV Cyclophosphamide

Cyclophosphamide (50 mg/kg) intravenously daily for 4 consecutive days (total 200 mg/kg) followed by granulocyte colony-stimulating factor (5 µg/kg/day)

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT00501995 - High Dose Cyclophosphamide for Treatment of Scleroderma | Biotech Hunter | Biotech Hunter